Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | coagulation factor II (thrombin) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0016 | 0.0493 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0016 | 0.0493 | 0.6467 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0493 | 0.0493 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.0763 | 0.2003 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0021 | 0.0763 | 1 |
Mycobacterium ulcerans | oxidoreductase | 0.0016 | 0.0493 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0016 | 0.0493 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.3809 | 0.3809 |
Loa Loa (eye worm) | hypothetical protein | 0.0192 | 0.9706 | 0.9706 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0079 | 0.3809 | 1 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0023 | 0.0845 | 0.0871 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0763 | 0.0763 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0021 | 0.0763 | 0.2003 |
Brugia malayi | SWIRM domain containing protein | 0.0086 | 0.4161 | 0.4287 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0079 | 0.3809 | 1 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0021 | 0.0763 | 0.2003 |
Echinococcus multilocularis | 0.0016 | 0.0493 | 0.1295 | |
Toxoplasma gondii | kringle domain-containing protein | 0.0021 | 0.0763 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0021 | 0.0763 | 0.0763 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0016 | 0.0493 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0021 | 0.0763 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0845 | 0.0845 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0016 | 0.0493 | 0.6467 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0016 | 0.0493 | 0.5 |
Mycobacterium ulcerans | monoamine oxidase | 0.0016 | 0.0493 | 0.5 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0493 | 0.0508 |
Onchocerca volvulus | 0.0086 | 0.4161 | 0.3679 | |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0079 | 0.3809 | 1 |
Onchocerca volvulus | CoRest homolog | 0.0198 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0021 | 0.0763 | 1 |
Brugia malayi | Kringle domain containing protein | 0.0021 | 0.0763 | 0.0786 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0016 | 0.0493 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.3809 | 0.3809 |
Schistosoma mansoni | amine oxidase | 0.0016 | 0.0493 | 0.1295 |
Brugia malayi | Protein kinase domain containing protein | 0.0021 | 0.0763 | 0.0786 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0016 | 0.0493 | 0.1295 |
Schistosoma mansoni | amine oxidase | 0.0016 | 0.0493 | 0.1295 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0016 | 0.0493 | 0.1295 |
Brugia malayi | Myb-like DNA-binding domain containing protein | 0.0192 | 0.9706 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0016 | 0.0493 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0016 | 0.0493 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0016 | 0.0493 | 0.1295 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0493 | 0.0493 |
Mycobacterium ulcerans | dehydrogenase | 0.0016 | 0.0493 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0021 | 0.0763 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.4161 | 0.4161 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
2x APTT (functional) | = 20.1 uM | Concentration required to double the activated partial thromboplastin time in human plasma | ChEMBL. | 15149685 |
Ki (binding) | = 0.077 uM | In vitro inhibition of human thrombin. | ChEMBL. | 15149685 |
Ki (binding) | = 0.077 uM | In vitro inhibition of human thrombin. | ChEMBL. | 15149685 |
Ki (binding) | > 500 uM | In vitro inhibition of Coagulation factor Xa. | ChEMBL. | 15149685 |
Ki (binding) | > 500 uM | In vitro inhibition of Coagulation factor Xa. | ChEMBL. | 15149685 |
Ki (binding) | > 700 uM | In vitro inhibition of bovine trypsin. | ChEMBL. | 15149685 |
Ki (binding) | > 700 uM | In vitro inhibition of bovine trypsin. | ChEMBL. | 15149685 |
pKa | = 6.1 | Dissociation constant of the compound was evaluated | ChEMBL. | 15149685 |
Selectivity (binding) | > 9091 | Selectivity for inhibition of thrombin over trypsin. | ChEMBL. | 15149685 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.